Other Headlines
Former Trade Desk pro from Siemens joins the DOTmed 100 company.
Gary Lee of DMS Topline Medical took some time to sit down with DOTmed News during the recent North Carolina Biomedical Association (NCBA).
The Canadian maker of high-end interventional MR suites acquires a prototype neurosurgery robot designed with aerospace technology in exchange for 1.6 million shares.
On-pump and off-pump bypass surgery yield similar results, reports the Harvard Heart Letter.
Two Idaho clinics are the latest to install NovaRad's NovaPACS to improve workflow and ease image access for interpreting and referring physicians.
Have News for Us?
Submit your news on the industry, people, or companies.
Forward to a FriendMore Industry Headlines
New Research Study Will Use fMRIs to Examine Soldiers' TBIs Research on traumatic brain injury will be used to determine faster treatment, safer vehicles.
Congress Submits Bill to Repeal Antitrust Exemption Reform measure would end exemption for health care, medical malpractice insurance.
White House to Convene Health Meeting President Obama promised a bipartisan event Feb. 25.
Las Vegas Spine Surgeon Pleads Guilty to Misprision of Felony A federal case review from the pages of DOTmed Business News.
FDA Issues Guidance on Facilitating Medical Device Clinical Trials Agency suggests statistical methods for cost and streamlining.
Philips Inks Three-Year Deal With SunCrest Philips' telemedicine division inked a three-year deal with the Sun Belt home care system SunCrest Healthcare, Inc.
HHS Highlights Health Care Investments in New Budget Budget includes health IT, research, public health measures.
Colorado Physicians Group Settles With FTC Over Alleged Price-Fixing Group accused of anti-competitive tactics against health insurers.
FDA Wants $4 Billion to Overhaul Medical Device, Food Safety Monitoring The injections of new cash could help establish a registry for medical devices and create over 1,000 new jobs.
NIH Discusses Dose Monitoring Program DOTmed News spoke with Dr. David Bluemke of the National Institutes of Health about the new program to require radiation dose monitoring on all equipment purchased by the NIH's Clinical Center.
Beamline wall construction
at Proton Therapy Center of
Central DuPage Hospital
at Proton Therapy Center of
Central DuPage Hospital
Proton Therapy Center Reaches Construction Milestone
April 21, 2009
by Barbara Kram, Editor
Warrenville, Ill. - The concrete for all four treatment rooms has been poured at the new proton therapy center in Warrenville, Ill., a joint endeavor by Central DuPage Hospital (CDH), Radiation Oncology Consultants and ProCure Treatment Centers, Inc. (ProCure). The 60,000 sq. ft. center will be one of only a handful of centers in the nation to offer proton therapy, an advanced form of radiation treatment for cancer.
"Despite the inclement weather and economic conditions, we are locked in on full financing for the Center and remain on schedule to begin treating patients by early 2011," said John Henderson, chief operating officer of ProCure. "With a third of the concrete in place, we anticipate completing the pour of 13,000 total yards of concrete before the middle of June - contingent on the weather, of course."
Construction began in December 2008. The estimated timeline for completion of the center is 26-28 months, following the world-record pace of the ProCure Proton Therapy Center in Oklahoma City, which is opening this summer.
"We are thrilled with the progress and extend our appreciation to the crew who has worked to keep this proton therapy center on schedule. The opening of this center will literally change the lives of thousands of patients and their families in and around Illinois," said Jim Spear, executive vice president and chief financial officer of CDH. "We are anxious to start treating those patients as soon as possible."
The development of the treatment center is creating about 400 temporary positions for construction and start-up operations and 100 full-time professional jobs when the center opens. Illinois-based contractors are constructing the facility.
There are currently five proton therapy centers operating in the United States treating multiple tumor sites, providing about 6,000 treatment slots per year. Another two centers are scheduled to open in 2009, including the ProCure Proton Therapy Center in Oklahoma City. ProCure also has centers under development in Michigan and Florida.
Experts conservatively estimate that every year, more than 10,000 Illinois cancer patients - and 250,000 nationwide - could benefit from proton therapy. Studies have shown proton therapy to be effective in treating brain, head and neck, pediatric and prostate tumors as well as cancers that cannot be removed completely by surgery. Research is showing promising results in the treatment of other tumors. Proton therapy can be particularly effective in treating children, who are more sensitive to the effects of radiation than adults.
Learn more about proton therapy and the center at www.ProtonTherapyIllinois.com.
ABOUT CENTRAL DUPAGE HOSPITAL
Central DuPage Hospital is a nationally recognized 313-bed facility located in Winfield, Ill., a suburb west of Chicago. CDH is a leading center for surgical innovations and was one of the first institutions in the nation to offer robotic-assisted surgery, minimally invasive spine surgery with bio-engineered bone protein and was the first Level III Neonatal Intensive Care Unit in DuPage County.
Recently, CDH was recognized for the second consecutive year by U.S. News & World Report on the list of Best Hospitals in the orthopaedics category. Thomson Reuter's has listed CDH as a 100 Top Hospital in the U.S. for the last three consecutive years.
The hospital is part of an interdependent network of health-care organizations and services, including convenient care centers, occupational health services and a full range of options for senior living, home health and hospice care. For more information or to find a doctor on the medical staff at CDH, visit www.cdh.org.
ABOUT PROCURE TREATMENT CENTERS, INC.
ProCure Treatment Centers, Inc., based in Bloomington, Ind., was founded in 2005 to improve the lives of patients with cancer by increasing access to proton therapy. ProCure collaborates with leading radiation oncology practices and hospitals and provides management leadership and a comprehensive approach for the design, construction, financing, staffing, training and day-to-day operations of world-class proton therapy centers. ProCure's solution reduces the time, cost and effort necessary to create a facility. ProCure is the only company in the world with two proton therapy centers under construction and two others in development. ProCure's Training and Development Center is the first facility in the world dedicated to proton therapy. For more information, visit www.procure.com.
ABOUT RADIATION ONCOLOGY CONSULTANTS LIMITED
Radiation Oncology Consultants Limited (ROCL), with headquarters in Park Ridge, Ill., is the largest private practice radiation oncology physician group in Illinois.
The practice, composed of 13 board certified radiation oncology physicians who provide cancer care to patients at multiple locations, has been an early adopter of leading technologies used in the treatment of cancer. These technologies include: 3-dimensional conformal radiation therapy, intensity modulated radiation therapy, Gamma Knife radiosurgery, TomoTherapy, prostate seed implants and high dose rate brachytherapy, and, soon, proton therapy. For more information, visit www.chicagocancer.com.
Read another important announcement from ProCure at:
http://www.dotmed.com/news/story/8974
Read a report on proton therapy in the May 2009 issue of DOTmed Business News.
"Despite the inclement weather and economic conditions, we are locked in on full financing for the Center and remain on schedule to begin treating patients by early 2011," said John Henderson, chief operating officer of ProCure. "With a third of the concrete in place, we anticipate completing the pour of 13,000 total yards of concrete before the middle of June - contingent on the weather, of course."
Construction began in December 2008. The estimated timeline for completion of the center is 26-28 months, following the world-record pace of the ProCure Proton Therapy Center in Oklahoma City, which is opening this summer.
"We are thrilled with the progress and extend our appreciation to the crew who has worked to keep this proton therapy center on schedule. The opening of this center will literally change the lives of thousands of patients and their families in and around Illinois," said Jim Spear, executive vice president and chief financial officer of CDH. "We are anxious to start treating those patients as soon as possible."
The development of the treatment center is creating about 400 temporary positions for construction and start-up operations and 100 full-time professional jobs when the center opens. Illinois-based contractors are constructing the facility.
There are currently five proton therapy centers operating in the United States treating multiple tumor sites, providing about 6,000 treatment slots per year. Another two centers are scheduled to open in 2009, including the ProCure Proton Therapy Center in Oklahoma City. ProCure also has centers under development in Michigan and Florida.
Experts conservatively estimate that every year, more than 10,000 Illinois cancer patients - and 250,000 nationwide - could benefit from proton therapy. Studies have shown proton therapy to be effective in treating brain, head and neck, pediatric and prostate tumors as well as cancers that cannot be removed completely by surgery. Research is showing promising results in the treatment of other tumors. Proton therapy can be particularly effective in treating children, who are more sensitive to the effects of radiation than adults.
Learn more about proton therapy and the center at www.ProtonTherapyIllinois.com.
ABOUT CENTRAL DUPAGE HOSPITAL
Central DuPage Hospital is a nationally recognized 313-bed facility located in Winfield, Ill., a suburb west of Chicago. CDH is a leading center for surgical innovations and was one of the first institutions in the nation to offer robotic-assisted surgery, minimally invasive spine surgery with bio-engineered bone protein and was the first Level III Neonatal Intensive Care Unit in DuPage County.
Recently, CDH was recognized for the second consecutive year by U.S. News & World Report on the list of Best Hospitals in the orthopaedics category. Thomson Reuter's has listed CDH as a 100 Top Hospital in the U.S. for the last three consecutive years.
The hospital is part of an interdependent network of health-care organizations and services, including convenient care centers, occupational health services and a full range of options for senior living, home health and hospice care. For more information or to find a doctor on the medical staff at CDH, visit www.cdh.org.
ABOUT PROCURE TREATMENT CENTERS, INC.
ProCure Treatment Centers, Inc., based in Bloomington, Ind., was founded in 2005 to improve the lives of patients with cancer by increasing access to proton therapy. ProCure collaborates with leading radiation oncology practices and hospitals and provides management leadership and a comprehensive approach for the design, construction, financing, staffing, training and day-to-day operations of world-class proton therapy centers. ProCure's solution reduces the time, cost and effort necessary to create a facility. ProCure is the only company in the world with two proton therapy centers under construction and two others in development. ProCure's Training and Development Center is the first facility in the world dedicated to proton therapy. For more information, visit www.procure.com.
ABOUT RADIATION ONCOLOGY CONSULTANTS LIMITED
Radiation Oncology Consultants Limited (ROCL), with headquarters in Park Ridge, Ill., is the largest private practice radiation oncology physician group in Illinois.
The practice, composed of 13 board certified radiation oncology physicians who provide cancer care to patients at multiple locations, has been an early adopter of leading technologies used in the treatment of cancer. These technologies include: 3-dimensional conformal radiation therapy, intensity modulated radiation therapy, Gamma Knife radiosurgery, TomoTherapy, prostate seed implants and high dose rate brachytherapy, and, soon, proton therapy. For more information, visit www.chicagocancer.com.
Read another important announcement from ProCure at:
http://www.dotmed.com/news/story/8974
Read a report on proton therapy in the May 2009 issue of DOTmed Business News.
Interested in Medical Industry News?
Subscribe to DOTmed's weekly news email and always be informed.
Click here, it takes just 30 seconds.
|
Please Send us your Comments. |
|
|
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2010 DOTmed.com, Inc.
ALL RIGHTS RESERVED
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2010 DOTmed.com, Inc.
ALL RIGHTS RESERVED
